Crowdsourced mapping crowdsourced C Cr Cro Crow BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 0 1 0 0 1
Anna Cichonska anna A An Ann Anna BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ,,*,*,*,, 9 9 0 0 0 0 1
Wan 6 wan W Wa Wan Wan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 0 ,,,,,--, 8 9 0 0 0 0 1
Minji Jeon minji M Mi Min Minj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,,,,,, 6 10 0 0 0 0 1
Jaewoo Kang jaewoo J Ja Jae Jaew BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,.,.,-- 7 8 0 0 0 0 1
Prediction Challenge prediction P Pr Pre Pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ,.,,., 6 9 0 0 0 0 1
Gustavo Stolovitzky gustavo G Gu Gus Gust BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ,,**,,,,,** 11 9 0 0 0 0 1
*shared first *shared * *s *sh *sha BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 * 1 10 0 0 0 0 1
**shared last **shared * ** **s **sh BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ** 2 10 0 0 0 0 1
Affiliations: Affiliations: affiliations: A Af Aff Affi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 : 1 1 0 0 0 0 1
1 Institute 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 4 (),,, 5 9 0 0 0 0 1
2 Department 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 4 ,(), 4 9 0 0 0 0 1
University, Espoo, university, U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 ,, 2 2 0 0 0 0 1
3 Department 3 3 3 3 3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 4 ,,, 3 7 0 0 0 0 1
4 Computational 4 4 4 4 4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 4 ,,,, 4 6 0 0 0 0 1
5 Department 5 5 5 5 5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 4 ,,, 3 9 0 0 0 0 1
6 Institute 6 6 6 6 6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 4 ,,,, 4 10 0 0 0 0 1
7 Department 7 7 7 7 7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 4 ,,, 3 7 0 0 0 0 1
8 Immuneering 8 8 8 8 8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 4 ,,, 3 4 0 0 0 0 1
9 Structural 9 9 9 9 9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 4 ,, 2 8 0 0 0 0 1
Carolina at carolina C Ca Car Caro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 4 ,,, 3 5 0 0 0 0 1
10 Translational 10 1 10 10 10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 4 ,,, 3 9 0 0 0 0 1
New Mexico, new N Ne New New BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 1 0 0 0 0 1
11 Department 11 1 11 11 11 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 4 ,,, 3 9 0 0 0 0 1
New York, new N Ne New New BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 1 0 0 0 0 1
12 IBM 12 1 12 12 12 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 4 ,,,, 4 6 0 0 0 0 1
13 Biotech 13 1 13 13 13 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 4 (),,, 5 8 0 0 0 0 1
Denmark Denmark denmark D De Den Denm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 4 no 0 0 0 0 0 0 1
14 Department 14 1 14 14 14 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 4 ,,, 3 8 0 0 0 0 1
15 Institute 15 1 15 15 15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 4 ,,, 3 7 0 0 0 0 1
16 Oslo 16 1 16 16 16 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 4 (),,, 5 9 0 0 0 0 1
Abstract Abstract abstract A Ab Abs Abst BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
Despite decades despite D De Des Desp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
proteins, there proteins, p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,- 2 10 0 0 0 0 1
human proteome. human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 9 0 0 0 0 1
unexplored compound-target unexplored u un une unex BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 -., 3 9 0 0 0 0 1
crowdsourced benchmarking crowdsourced c cr cro crow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 () 2 9 0 0 0 0 1
kinase inhibitor kinase k ki kin kina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 9 0 0 0 0 1
scored in scored s sc sco scor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .-, 3 9 0 0 0 0 1
gradient boosting gradient g gr gra grad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 0 0 0 0 1
assays. Subsequent assays. a as ass assa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .- 2 9 0 0 0 0 1
demonstrated that demonstrated d de dem demo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
mapping efforts, mapping m ma map mapp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,-.- 4 9 0 0 0 0 1
together with together t to tog toge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 9 0 0 0 0 1
295 kinases 295 2 29 295 295 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 0 . 1 7 0 0 0 0 1
Introduction Introduction introduction I In Int Intr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 10 0 0 0 0 1
Despite many despite D De Des Desp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 -, 2 9 0 0 0 0 1
targets are targets t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 .,, 3 9 0 0 0 0 1
therapeutic efficacy therapeutic t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 -. 2 9 0 0 0 0 1
Even if even E Ev Eve Even BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 ,- 2 9 0 0 0 0 1
approaches may approaches a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 . 1 8 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 10 0 0 0 0 1
promiscuous agents, promiscuous p pr pro prom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 9 0 0 0 0 1
to further to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 (..,-- 6 9 0 0 0 0 1
process). Novel process). p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ).- 3 8 0 0 0 0 1
application area application a ap app appl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ., 2 8 0 0 0 0 1
makes experimental makes m ma mak make BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 -, 2 9 0 0 0 0 1
with automated with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 -. 2 4 0 0 0 0 1
To address to T To To To BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 ,-- 3 8 0 0 0 0 1
Challenge, a challenge, C Ch Cha Chal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 ,-() 4 8 0 0 0 0 1
models as models m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 -- 2 8 0 0 0 0 1
potencies that potencies p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 (..,). 6 10 0 0 0 0 1
on kinase on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 , 1 9 0 0 0 0 1
range of range r ra ran rang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ,., 3 8 0 0 0 0 1
domains share domains d do dom doma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 , 1 9 0 0 0 0 1
ATP-binding pockets, atp-binding A AT ATP ATP- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 8 -, 2 8 0 0 0 0 1
effects. 3-5 effects. e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 .-, 3 9 0 0 0 0 1
AI approaches, ai A AI AI AI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 0 8 , 1 9 0 0 0 0 1
to predict to t to to to BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 . 1 5 0 0 0 0 1
The Challenge the T Th The The BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 -,- 3 9 0 0 0 0 1
collaboration with collaboration c co col coll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -() 3 8 0 0 0 0 1
( https://commonfund.nih.gov/idg ( ( ( ( ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 0 (://../),- 10 9 0 0 0 0 1
of small-molecule of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -, 2 9 0 0 0 0 1
providing activity providing p pr pro prov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -. 2 9 0 0 0 0 1
sought to sought s so sou soug BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 :() 3 9 0 0 0 0 1
quantitative compound-target quantitative q qu qua quan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -?;() 5 10 0 0 0 0 1
descriptors for descriptors d de des desc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ?;() 4 9 0 0 0 0 1
assays and assays a as ass assa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ?, 2 9 0 0 0 0 1
total of total t to tot tota BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,, 2 9 0 0 0 0 1
and kernel and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ., 2 9 0 0 0 0 1
results from results r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 ,- 2 9 0 0 0 0 1
inhibitor activities. inhibitor i in inh inhi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 2 0 0 0 0 1
Results Results results R Re Res Resu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 6 no 0 10 0 0 0 0 1
Challenge implementation challenge C Ch Cha Chal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 2 0 0 0 0 1
To develop to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 6 , 1 9 0 0 0 0 1
data for data d da dat data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 -, 2 8 0 0 0 0 1
BindingDB 7 bindingdb B Bi Bin Bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 (.).,, 6 9 0 0 0 0 1
harmonization, the harmonization, h ha har harm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ,-,(). 6 9 0 0 0 0 1
DTC is dtc D DT DTC DTC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 , 1 9 0 0 0 0 1
provides a provides p pr pro prov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 - 1 9 0 0 0 0 1
related information related r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 (..). 5 9 0 0 0 0 1
was built was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ,, 2 10 0 0 0 0 1
and scoring and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 '- 2 9 0 0 0 0 1
data and data d da dat data BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 (.). 4 7 0 0 0 0 1
Figure 1 figure F Fi Fig Figu BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 .--. 4 8 1 0 0 0 1
heatmap on heatmap h he hea heat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (.. 3 10 1 0 0 0 1
matrices, and matrices, m ma mat matr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,..). 5 5 1 0 0 0 1
Challenge test challenge C Ch Cha Chal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 1 no 0 2 1 0 0 0 1
Evaluation of evaluation E Ev Eva Eval BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 1 no 0 9 1 0 0 0 1
the IDG the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 ,"" 3 8 1 0 0 0 1
based on based b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 (..). 5 10 1 0 0 0 1
1 was 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 1 --., 4 9 1 0 0 0 1
was followed was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 -() 3 9 1 0 0 0 1
compound-kinase pairs compound-kinase c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 1 - 1 9 1 0 0 0 1
public domain public p pu pub publ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 (). 3 9 1 0 0 0 1
Round 2, round R Ro Rou Roun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 1 ,- 2 8 1 0 0 0 1
single-dose inhibition single-dose s si sin sing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 -., 3 9 1 0 0 0 1
of 95 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 (.-), 5 9 1 0 0 0 1
multiple kinases multiple m mu mul mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 ,, 2 9 1 0 0 0 1
compounds with compounds c co com comp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 (..). 5 7 1 0 0 0 1
Round 1 round R Ro Rou Roun BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 8 no 0 9 0 0 0 0 1
resources, whereas resources, r re res reso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 ,,, 3 8 0 0 0 0 1
prediction models prediction p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 -. 2 9 0 0 0 0 1
similar K similar s si sim simi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 (.), 4 10 0 0 0 0 1
monitor the monitor m mo mon moni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 . 1 9 0 0 0 0 1
sets were sets s se set sets BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 (.), 4 9 0 0 0 0 1
compounds with compounds c co com comp BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (.),- 5 9 1 0 0 0 1
pairs (pK pairs p pa pai pair BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()., 4 9 1 0 0 0 1
kinase families kinase k ki kin kina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (.,)., 6 9 1 0 0 0 1
standardized and standardized s st sta stan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
predicting on-and predicting p pr pre pred BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 --. 3 4 1 0 0 0 1
Figure 2. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 3 ..() 4 8 1 0 0 0 1
compounds and compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 ,() 3 9 1 0 0 0 1
(E). (C) (e). ( (E (E) (E). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 3 ().()()- 8 9 1 0 0 0 1
in dose-response in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 3 -(),-(). 8 10 1 0 0 0 1
The higher the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 3 , 1 10 1 0 0 0 1
(Suppl. Fig. (suppl. ( (S (Su (Sup BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 3 (..).() 7 9 1 0 0 0 1
index for index i in ind inde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 -() 3 8 1 0 0 0 1
across full across a ac acr acro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 -. 2 9 1 0 0 0 1
with KinMap, with w wi wit with BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 ,,. 3 6 1 0 0 0 1
Overall performance overall O Ov Ove Over BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 3 0 0 0 0 1
The competition the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
compounds and compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 8 0 0 0 0 1
regression approach regression r re reg regr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -" 2 8 0 0 0 0 1
model" 12 model" m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ". 2 9 0 0 0 0 1
measured by measured m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (-,.;.) 7 8 0 0 0 0 1
Mean Square mean M Me Mea Mean BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 (,-;.). 7 9 0 0 0 0 1
that the that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (..), 5 10 0 0 0 0 1
proportion of proportion p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (,.)., 6 9 0 0 0 0 1
compared the compared c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 9 0 0 0 0 1
we observed we w we we we BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 0 0 0 0 1
in Round in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 0 ().,, 5 9 0 0 0 0 1
compared to compared c co com comp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (). 3 3 0 0 0 0 1
The 20 the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 (.. 3 10 0 0 0 0 1
for Spearman for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ,-), 4 9 0 0 0 0 1
baseline model, baseline b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 ,(.)., 6 9 0 0 0 0 1
individual teams individual i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 () 2 9 0 0 0 0 1
between the between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 9 0 0 0 0 1
on experimental on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 (.,). 5 9 0 0 0 0 1
top-performing models top-performing t to top top- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 -, 2 9 0 0 0 0 1
Spearman correlation spearman S Sp Spe Spea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 2 6 ; 1 9 0 0 0 0 1
showed less showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 -(.). 5 9 0 0 0 0 1
breaking metric, breaking b br bre brea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ,(), 4 9 0 0 0 0 1
prediction accuracies prediction p pr pre pred BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 (..). 5 9 0 0 0 0 1
Figure 3. figure F Fi Fig Figu BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ..(,) 5 9 1 0 0 0 1
terms of terms t te ter term BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ()(). 5 9 1 0 0 0 1
baseline model baseline b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 -. 2 8 1 0 0 0 1
submissions that submissions s su sub subm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 1 0 0 0 1
same in same s sa sam same BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 .(,)( 5 8 1 0 0 0 1
permuted pK permuted p pe per perm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 )( 2 9 1 0 0 0 1
of overlapping of o of of of BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -,) 3 10 1 0 0 0 1
(top panel) (top ( (t (to (top BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ()()..(,) 9 9 0 0 0 0 1
Relationship of relationship R Re Rel Rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 0 0 0 0 1
shape indicates shape s sh sha shap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ()., 4 8 0 0 0 0 1
DMIS_DK submitted dmis_dk D DM DMI DMIS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 ()() 4 8 0 0 0 0 1
algorithms in algorithms a al alg algo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,()., 5 10 0 0 0 0 1
approaches did approaches a ap app appr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 8 0 0 0 0 1
Analysis of analysis A An Ana Anal BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 - 1 3 0 0 0 0 1
The top-performing the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 - 1 9 0 0 0 0 1
compounds and compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 ., 2 9 0 0 0 0 1
method write-ups method m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 --. 3 9 0 0 0 0 1
the top-performers the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 -,, 3 9 0 0 0 0 1
a bootstrap a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 2 3 ', 2 9 0 0 0 0 1
(K) relative (k) ( (K (K) (K) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 ()(..). 7 9 0 0 0 0 1
Considering Spearman considering C Co Con Cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 ,-..(;.). 9 9 0 0 0 0 1
RMSE metric, rmse R RM RMS RMSE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 ,-()(; 6 8 0 0 0 0 1
Suppl. Fig. suppl. S Su Sup Supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 ..),-(.; 8 10 0 0 0 0 1
Fig. 4B). fig. F Fi Fig Fig. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 .).-() 6 9 0 0 0 0 1
comparable performance. comparable c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 ., 2 9 0 0 0 0 1
teams in teams t te tea team BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 (..). 5 3 0 0 0 0 1
Figure 4 figure F Fi Fig Figu BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 .-.() 5 8 1 0 0 0 1
correlation sub-challenge correlation c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 --,...()- 9 8 1 0 0 0 1
top-performer in top-performer t to top top- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -,.() 5 10 1 0 0 0 1
models selected models m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 10 1 0 0 0 1
394 compound-kinase 394 3 39 394 394 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 0 -.() 4 9 1 0 0 0 1
aggregation ensemble aggregation a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 8 1 0 0 0 1
top-performing models top-performing t to top top- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -, 2 9 1 0 0 0 1
dropped below dropped d dr dro drop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ..( 3 9 1 0 0 0 1
in the in i in in in BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 ,..). 5 6 1 0 0 0 1
Notably, the notably, N No Not Nota BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ,-, 3 8 0 0 0 0 1
learning, graph learning, l le lea lear BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,,, 3 9 0 0 0 0 1
regularized regression regularized r re reg regu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 (). 3 9 0 0 0 0 1
approaches could approaches a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 0 0 0 0 1
mean aggregation mean m me mea mean BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -. 2 8 0 0 0 0 1
combination of combination c co com comb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (. 2 9 0 0 0 0 1
4C), demonstrating 4c), 4 4C 4C) 4C), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 ),., 4 9 0 0 0 0 1
ensemble prediction ensemble e en ens ense BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 9 0 0 0 0 1
correlation and correlation c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (.)., 5 9 0 0 0 0 1
had a had h ha had had BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (;..). 6 10 0 0 0 0 1
suggests that suggests s su sug sugg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
accurate and accurate a ac acc accu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 0 0 0 0 1
A A a A A A A BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 3 4 no 0 1 0 0 0 0 1
Team Algorithm team T Te Tea Team BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 10 0 0 0 0 1
Algorithm Names algorithm A Al Alg Algo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 8 0 0 0 0 1
Combined Combined combined C Co Com Comb BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 5 0 0 0 0 1
Models Models models M Mo Mod Mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 3 0 0 0 0 1
Training Strategy training T Tr Tra Trai BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 4 no 0 10 0 0 0 0 1
DMIS_DK Deep dmis_dk D DM DMI DMIS BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 10 0 0 0 0 1
Graph Neural graph G Gr Gra Grap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 10 0 0 0 0 1
12 12 12 1 12 12 12 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 5 no 0 1 0 0 0 0 1
Train test train T Tr Tra Trai BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 7 0 0 0 0 1
AI Winter ai A AI AI AI BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 3 5 no 0 10 0 0 0 0 1
Coming Coming coming C Co Com Comi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 5 0 0 0 0 1
Gradient boosting gradient G Gr Gra Grad BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 10 0 0 0 0 1
trees trees trees t tr tre tree BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 2 0 0 0 0 1
XGboost XGboost xgboost X XG XGb XGbo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 2 0 0 0 0 1
5 per 5 5 5 5 5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 5 no 0 4 0 0 0 0 1
K-fold nested k-fold K K- K-f K-fo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 - 1 9 0 0 0 0 1
validation, boosting validation, v va val vali BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 10 0 0 0 0 1
Q.E.D Kernel q.e.d Q Q. Q.E Q.E. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 .. 2 10 0 0 0 0 1
CGKronRLS CGKronRLS cgkronrls C CG CGK CGKr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 no 0 4 0 0 0 0 1
440 440 440 4 44 440 440 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 6 no 0 1 0 0 0 0 1
Boosting Boosting boosting B Bo Boo Boos BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 4 0 0 0 0 1
Gregory Koytiger gregory G Gr Gre Greg BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 6 no 0 10 0 0 0 0 1
Not applicable not N No Not Not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 4 0 0 0 0 1
6 6 6 6 6 6 6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 6 no 0 0 0 0 0 0 1
Fixed hold fixed F Fi Fix Fixe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 4 0 0 0 0 1
Olivier Labayle olivier O Ol Oli Oliv BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 6 no 0 10 0 0 0 0 1
Not applicable not N No Not Not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 4 0 0 0 0 1
Not applicable not N No Not Not BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 4 0 0 0 0 1
K-fold cross k-fold K K- K-f K-fo BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 - 1 10 0 0 0 0 1
validation validation validation v va val vali BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 8 0 0 0 0 1
Baseline Kernel baseline B Ba Bas Base BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 10 0 0 0 0 1
CGKronRLS CGKronRLS cgkronrls C CG CGK CGKr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 4 0 0 0 0 1
1 1 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 7 no 0 0 0 0 0 0 1
K-fold nested k-fold K K- K-f K-fo BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 - 1 10 0 0 0 0 1
validation validation validation v va val vali BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 5 0 0 0 0 1
B B b B B B B BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 7 no 0 0 0 0 0 0 1
Team Training team T Te Tea Team BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 10 0 0 0 0 1
Compound- Compound- compound- C Co Com Comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 - 1 5 0 0 0 0 1
Protein Pairs protein P Pr Pro Prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 7 0 0 0 0 1
Bioactivity Types bioactivity B Bi Bio Bioa BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 10 0 0 0 0 1
Protein Protein protein P Pr Pro Prot BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 5 0 0 0 0 1
Representation Representation representation R Re Rep Repr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 10 0 0 0 0 1
Chemical Chemical chemical C Ch Che Chem BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 6 0 0 0 0 1
Representation Representation representation R Re Rep Repr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 10 0 0 0 0 1
DMIS_DK DMIS_DK dmis_dk D DM DMI DMIS BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
DrugTargetCommons, DrugTargetCommons, drugtargetcommons, D Dr Dru Drug BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 , 1 10 0 0 0 0 1
BindingDB BindingDB bindingdb B Bi Bin Bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 5 0 0 0 0 1
953521 953521 953521 9 95 953 9535 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 8 no 0 3 0 0 0 0 1
K d k K K K K BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 ,, 2 9 0 0 0 0 1
None None none N No Non None BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 2 0 0 0 0 1
2D molecular 2d 2 2D 2D 2D BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
graphs graphs graphs g gr gra grap BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 5 0 0 0 0 1
AI Winter ai A AI AI AI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
Coming Coming coming C Co Com Comi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 5 0 0 0 0 1
DrugTargetCommons, DrugTargetCommons, drugtargetcommons, D Dr Dru Drug BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 , 1 7 0 0 0 0 1
ChEMBL ChEMBL chembl C Ch ChE ChEM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 2 0 0 0 0 1
600000 600000 600000 6 60 600 6000 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 8 no 0 2 0 0 0 0 1
K d k K K K K BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 ,,, 3 10 0 0 0 0 1
None None none N No Non None BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 1 0 0 0 0 1
ECFP5, ECFP7, ecfp5, E EC ECF ECFP BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 ,, 2 10 0 0 0 0 1
ECFP9, ECFP11 ecfp9, E EC ECF ECFP BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 , 1 10 0 0 0 0 1
Q.E.D Q.E.D q.e.d Q Q. Q.E Q.E. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 .. 2 10 0 0 0 0 1
DrugTargetCommons, DrugTargetCommons, drugtargetcommons, D Dr Dru Drug BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 , 1 10 0 0 0 0 1
ChEMBL, Uniprot chembl, C Ch ChE ChEM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 , 1 8 0 0 0 0 1
60462 60462 60462 6 60 604 6046 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 9 no 0 3 0 0 0 0 1
K d k K K K K BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 9 ,, 2 9 0 0 0 0 1
Amino acid amino A Am Ami Amin BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 8 0 0 0 0 1
sequences sequences sequences s se seq sequ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 7 0 0 0 0 1
ECFP4, ECFP6 ecfp4, E EC ECF ECFP BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 , 1 10 0 0 0 0 1
Gregory Gregory gregory G Gr Gre Greg BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 10 no 0 4 0 0 0 0 1
Koytiger ChEMBL koytiger K Ko Koy Koyt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 8 0 0 0 0 1
250000 250000 250000 2 25 250 2500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 3 10 no 0 3 0 0 0 0 1
K d k K K K K BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 ,, 2 10 0 0 0 0 1
None None none N No Non None BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 2 0 0 0 0 1
None None none N No Non None BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 2 0 0 0 0 1
Olivier Labayle olivier O Ol Oli Oliv BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 10 no 0 10 0 0 0 0 1
DrugTargetCommons, DrugTargetCommons, drugtargetcommons, D Dr Dru Drug BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 , 1 10 0 0 0 0 1
ChEMBL, Uniprot chembl, C Ch ChE ChEM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 , 1 8 0 0 0 0 1
18200 18200 18200 1 18 182 1820 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 3 10 no 0 3 0 0 0 0 1
K d k K K K K BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 2 0 0 0 0 1
K-mer counting k-mer K K- K-m K-me BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 - 1 7 0 0 0 0 1
ECFP ECFP ecfp E EC ECF ECFP BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 2 0 0 0 0 1
Baseline DrugTargetCommons baseline B Ba Bas Base BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
44186 44186 44186 4 44 441 4418 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 11 no 0 2 0 0 0 0 1
K d k K K K K BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 1 0 0 0 0 1
Amino acid amino A Am Ami Amin BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
sequences sequences sequences s se seq sequ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 11 no 0 9 0 0 0 0 1
Path-based Path-based path-based P Pa Pat Path BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 - 1 8 0 0 0 0 1
fingerprints fingerprints fingerprints f fi fin fing BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 11 no 0 10 0 0 0 0 1
Table 1. table T Ta Tab Tabl BLOCKSTART PAGEEND NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 .-. 3 10 0 0 0 0 1
Comparison against comparison C Co Com Comp BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 3 0 0 0 0 1
We next we W We We We BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 -- 2 8 0 0 0 0 1
activity assays activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 0 0 0 0 1
screening studies screening s sc scr scre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 0 0 0 1
selecting most selecting s se sel sele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -,-. 4 9 0 0 0 0 1
this classification this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 0 0 0 0 1
potencies, which potencies, p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,, 2 9 0 0 0 0 1
analyses that analyses a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -(.). 5 9 0 0 0 0 1
Using the using U Us Usi Usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 ---, 4 9 0 0 0 0 1
similar to similar s si sim simi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,,,() 5 10 0 0 0 0 1
(FDR) of (fdr) ( (F (FD (FDR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ()-... 6 8 0 0 0 0 1
using the using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 8 0 0 0 0 1
models and models m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -, 2 8 0 0 0 0 1
observed an observed o ob obs obse BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ... 3 5 0 0 0 0 1
We further we W We We We BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 -, 2 9 0 0 0 0 1
2 pairs 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 6 -- 2 9 0 0 0 0 1
assay values, assay a as ass assa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 ,- 2 8 0 0 0 0 1
(pK d (pk ( (p (pK (pK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 (). 3 9 0 0 0 0 1
classification accuracy classification c cl cla clas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 -(.), 5 8 0 0 0 0 1
especially when especially e es esp espe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 - 1 8 0 0 0 0 1
specificity that specificity s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 no 0 10 0 0 0 0 1
multi-dose validation. multi-dose m mu mul mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 -. 2 9 0 0 0 0 1
making any making m ma mak maki BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 , 1 8 0 0 0 0 1
precision-recall analysis, precision-recall p pr pre prec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 -, 2 9 0 0 0 0 1
above PPV=75% above a ab abo abov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 ()(.). 6 8 0 0 0 0 1
expected, the expected, e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 ,- 2 9 0 0 0 0 1
7 (Suppl. 7 7 7 7 7 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 6 (..),. 6 8 0 0 0 0 1
Figure 5. figure F Fi Fig Figu BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 .--.() 6 8 1 0 0 0 1
Receiver operating receiver R Re Rec Rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 ()- 3 9 1 0 0 0 1
from Round from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -( 2 9 1 0 0 0 1
from Q.E.D, from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ..,)- 5 9 1 0 0 0 1
assays ( assays a as ass assa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (). 3 10 1 0 0 0 1
ROC curve roc R RO ROC ROC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 9 1 0 0 0 1
prediction accuracy prediction p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -..()-() 8 9 1 0 0 0 1
classification analysis classification c cl cla clas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 1 0 0 0 1
parentheses and parentheses p pa par pare BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 .. 2 8 1 0 0 0 1
Sensitivity=Recall. Precision=PPV. sensitivity=recall. S Se Sen Sens BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 .. 2 3 1 0 0 0 1
Since the since S Si Sin Sinc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 -- 2 8 0 0 0 0 1
compound-kinase pairs compound-kinase c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 --, 3 9 0 0 0 0 1
dataset enables dataset d da dat data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 - 1 9 0 0 0 0 1
assays or assays a as ass assa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ., 2 9 0 0 0 0 1
limited for limited l li lim limi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (.., 4 10 0 0 0 0 1
> 6, > > > > > BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 5 ,-). 4 9 0 0 0 0 1
between single-dose between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 -- 2 9 0 0 0 0 1
inhibition values inhibition i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 0 0 0 1
misses the misses m mi mis miss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 --. 3 9 0 0 0 0 1
is why is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 9 0 0 0 0 1
pK d pk p pK pK pK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 9 0 0 0 0 1
single-dose assays single-dose s si sin sing BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 -. 2 3 0 0 0 0 1
Model-based target model-based M Mo Mod Mode BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 3 0 0 0 0 1
To explore to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 --, 3 9 0 0 0 0 1
we experimentally we w we we we BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,, 2 9 0 0 0 0 1
based solely based b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -.- 3 9 0 0 0 0 1
experiments were experiments e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 8 0 0 0 0 1
selectivity, kinase selectivity, s se sel sele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ,,, 3 10 0 0 0 0 1
possible to possible p po pos poss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
single-dose inhibition; single-dose s si sin sing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -;-- 4 9 0 0 0 0 1
testing 5,11,13 testing t te tes test BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 0 ,,., 4 9 0 0 0 0 1
according to according a ac acc acco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -(.,)., 7 9 0 0 0 0 1
model-based approach model-based m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -() 3 9 0 0 0 0 1
based on based b ba bas base BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ;. 2 7 0 0 0 0 1
As an as A As As As BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 4 -,- 3 9 0 0 0 0 1
predicted PYK2 predicted p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 ()-(.). 7 9 0 0 0 0 1
multi-dose pK multi-dose m mu mul mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 4 -- 2 9 0 0 0 0 1
to its to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 (.,). 5 10 0 0 0 0 1
PLK inhibitor plk P PL PLK PLK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 4 ,,(). 5 9 0 0 0 0 1
Neither PYK2 neither N Ne Nei Neit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 4 - 1 9 0 0 0 0 1
testing alone, testing t te tes test BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 4 ,(.,)., 7 9 0 0 0 0 1
dose-testing had dose-testing d do dos dose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 --, 3 9 0 0 0 0 1
than PLKs than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 -- 2 8 0 0 0 0 1
dose-response K dose-response d do dos dose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 -,., 4 9 0 0 0 0 1
out to out o ou out out BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 ,(.,). 6 9 0 0 0 0 1
Another unexpected another A An Ano Anot BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 8 no 0 9 0 0 0 0 1
against DDR1 against a ag aga agai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 ,(.,). 6 9 0 0 0 0 1
single-dose testing single-dose s si sin sing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 - 1 9 0 0 0 0 1
AURKB (Fig. aurkb A AU AUR AURK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 (.,),- 6 9 0 0 0 0 1
higher level higher h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 ()., 4 9 0 0 0 0 1
these high these t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 ,,- 3 10 0 0 0 0 1
bioactivity data bioactivity b bi bio bioa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 . 1 9 0 0 0 0 1
can identify can c ca can can BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 - 1 10 0 0 0 0 1
single-dose assays single-dose s si sin sing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 -. 2 9 0 0 0 0 1
could have could c co cou coul BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 -(.). 5 9 0 0 0 0 1
compound was compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 () 2 9 0 0 0 0 1
against FLT1. against a ag aga agai BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 . 1 1 0 0 0 0 1
Figure 6. figure F Fi Fig Figu BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 .-.()- 6 8 1 0 0 0 1
inhibition assay inhibition i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ()-- 4 9 1 0 0 0 1
pairs (394 pairs p pa pai pair BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (). 3 9 1 0 0 0 1
negatives and negatives n ne neg nega BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 9 1 0 0 0 1
among the among a am amo amon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ( 1 9 1 0 0 0 1
the dose-response the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -,.,). 6 9 1 0 0 0 1
validations based validations v va val vali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,. 2 9 1 0 0 0 1
single-dose and single-dose s si sin sing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -- 2 9 1 0 0 0 1
previous studies. previous p pr pre prev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 9 1 0 0 0 1
pK d pk p pK pK pK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ',- 3 9 1 0 0 0 1
dose-response assays. dose-response d do dos dose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -.()-()-() 10 9 1 0 0 0 1
with TPKI-30. with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -. 2 8 1 0 0 0 1
predictions, whereas predictions, p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,. 2 9 1 0 0 0 1
predictions based predictions p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -.- 3 9 1 0 0 0 1
predicted TPKI-30 predicted p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -//,- 5 9 1 0 0 0 1
confirmed it confirmed c co con conf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 .()-()-() 9 10 1 0 0 0 1
tested with tested t te tes test BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 9 1 0 0 0 1
model predictions, model m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,. 2 9 1 0 0 0 1
positive predictions positive p po pos posi BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -.() 4 9 1 0 0 0 1
accuracy of accuracy a ac acc accu BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -()- 4 9 0 0 0 0 1
assay (at assay a as ass assa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 () 2 10 0 0 0 0 1
or higher or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .- 2 10 0 0 0 0 1
(AUC) as (auc) ( (A (AU (AUC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ()--,- 6 9 0 0 0 0 1
inhibition>x%, and inhibition>x%, i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 , 1 9 0 0 0 0 1
cut-off threshold. cut-off c cu cut cut- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -. 2 8 0 0 0 0 1
expected inhibition expected e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 9 0 0 0 0 1
top-performing model top-performing t to top top- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -(...,).() 10 9 0 0 0 0 1
operating characteristic operating o op ope oper BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ()()-()(), 10 9 0 0 0 0 1
ranking all ranking r ra ran rank BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -- 2 9 0 0 0 0 1
measured single-dose measured m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -( 2 9 0 0 0 0 1
measured pK measured m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 )., 3 9 0 0 0 0 1
indicates the indicates i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -.(), 5 9 0 0 0 0 1
indicates the indicates i in ind indi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .()... 6 8 0 0 0 0 1
Surprisingly, the surprisingly, S Su Sur Surp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 4 ,-- 3 6 0 0 0 0 1
predictions were predictions p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 no 0 2 0 0 0 0 1
uncorrelated (Suppl. uncorrelated u un unc unco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 (..,.), 7 9 0 0 0 0 1
K d k K K K K BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 4 -(.). 5 9 0 0 0 0 1
two activity two t tw two two BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ,- 2 8 0 0 0 0 1
measured and measured m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 - 1 7 0 0 0 0 1
top-performing models, top-performing t to top top- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 -,. 3 8 0 0 0 0 1
classifications beyond classifications c cl cla clas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ,, 2 9 0 0 0 0 1
identified a identified i id ide iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 --, 3 9 0 0 0 0 1
compared to compared c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 -(.,). 6 9 0 0 0 0 1
the sensitivity the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 (.,), 5 10 0 0 0 0 1
and especially and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 - 1 9 0 0 0 0 1
experimental validation experimental e ex exp expe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 (.,). 5 4 0 0 0 0 1
Discussion Discussion discussion D Di Dis Disc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 1 0 0 0 0 1
Experimental mapping experimental E Ex Exp Expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 -' 2 9 0 0 0 0 1
mode of mode m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 (), 3 9 0 0 0 0 1
consuming and consuming c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 .,, 3 9 0 0 0 0 1
consist of consist c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 ,, 2 9 0 0 0 0 1
experimental bioactivity experimental e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 9 0 0 0 0 1
practice. ML practice. p pr pra prac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 .-, 3 9 0 0 0 0 1
shown their shown s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 9 0 0 0 0 1
and development. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 .- 2 8 0 0 0 0 1
benchmark state-of-the-art benchmark b be ben benc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 --- 3 9 0 0 0 0 1
by combining by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 ., 2 10 0 0 0 0 1
Challenge participants challenge C Ch Cha Chal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 8 0 0 0 0 1
mapping efforts mapping m ma map mapp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 - 1 9 0 0 0 0 1
further experimental further f fu fur furt BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 .- 2 9 0 0 0 0 1
(i) phenotype-based (i) ( (i (i) (i) BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ()-(..), 8 9 0 0 0 0 1
and (ii) and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ()-(.. 6 10 0 0 0 0 1
inhibit a inhibit i in inh inhi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -). 3 4 0 0 0 0 1
Although previous although A Al Alt Alth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
gaps in gaps g ga gap gaps BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -, 2 8 0 0 0 0 1
comparisons of comparisons c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ,. 2 8 0 0 0 0 1
therefore encouraged therefore t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 9 0 0 0 0 1
In the in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 0 ,, 2 10 0 0 0 0 1
out. Rather, out. o ou out out. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .,-(). 6 9 0 0 0 0 1
the top-performing the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -, 2 8 0 0 0 0 1
information. Furthermore, information. i in inf info BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .,- 3 8 0 0 0 0 1
chemical information, chemical c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 9 0 0 0 0 1
and target and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .,() 4 8 0 0 0 0 1
proposed for proposed p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -,- 3 9 0 0 0 0 1
outperforming other outperforming o ou out outp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 .-- 3 8 0 0 0 0 1
performer (Q.E.D) performer p pe per perf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 (..), 5 9 0 0 0 0 1
showing markedly showing s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 (.),, 5 9 0 0 0 0 1
implementation, or implementation, i im imp impl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ,,. 3 9 0 0 0 0 1
A number a A A A A BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 5 0 (..). 5 9 0 0 0 0 1
To get to T To To To BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 5 , 1 9 0 0 0 0 1
questionnaires to questionnaires q qu que ques BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 8 0 0 0 0 1
target features target t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ., 2 8 0 0 0 0 1
none of none n no non none BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (..), 5 8 0 0 0 0 1
similarly as similarly s si sim simi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 .- 2 9 0 0 0 0 1
from the from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 8 0 0 0 0 1
also other also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -(..,,), 8 10 0 0 0 0 1
alone (Suppl. alone a al alo alon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (..). 5 9 0 0 0 0 1
relatively large relatively r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 , 1 9 0 0 0 0 1
so far so s so so so BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 5 -,(. 4 9 0 0 0 0 1
Fig. 11G). fig. F Fi Fig Fig. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 5 .). 3 9 0 0 0 0 1
data source data d da dat data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 , 1 8 0 0 0 0 1
heterogeneous bioactivity heterogeneous h he het hete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ,. 2 8 0 0 0 0 1
suggests that suggests s su sug sugg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 8 0 0 0 0 1
bioactivity data bioactivity b bi bio bioa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 , 1 9 0 0 0 0 1
the form the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 . 1 4 0 0 0 0 1
Many previous many M Ma Man Many BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 10 '' 2 8 0 0 0 0 1
improve the improve i im imp impr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 no 0 8 0 0 0 0 1
meta-predictors or meta-predictors m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 10 -.- 3 9 0 0 0 0 1
based on based b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 no 0 10 0 0 0 0 1
adding more adding a ad add addi BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 (.). 4 9 0 0 0 0 1
drug-target interaction drug-target d dr dru drug BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -' 2 9 0 0 0 0 1
teams'. The teams'. t te tea team BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 '.- 3 9 0 0 0 0 1
specificity, compared specificity, s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ,-, 3 9 0 0 0 0 1
experiments (Fig. experiments e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (.).--, 7 9 0 0 0 0 1
and we and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 8 0 0 0 0 1
higher prediction higher h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 9 0 0 0 0 1
potent compound-kinase potent p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 --(.). 6 9 0 0 0 0 1
The best-performing the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 9 0 0 0 0 1
data, provided data, d da dat data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 10 0 0 0 0 1
predicted. Subsequent predicted. p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .- 2 8 0 0 0 0 1
predictions demonstrated predictions p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 9 0 0 0 0 1
especially for especially e es esp espe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -(.,). 6 5 0 0 0 0 1
To enable to T To To To BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 9 0 0 0 0 1
development applications, development d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 4 ,- 2 8 0 0 0 0 1
containerized source containerized c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 . 1 8 0 0 0 0 1
predictions whenever predictions p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 , 1 9 0 0 0 0 1
enable the enable e en ena enab BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 9 0 0 0 0 1
remain closed remain r re rem rema BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 .,, 3 9 0 0 0 0 1
contribute to contribute c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 9 0 0 0 0 1
prediction models prediction p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 . 1 9 0 0 0 0 1
instance, for instance, i in ins inst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ,,- 3 10 0 0 0 0 1
predictions for predictions p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 .,, 3 9 0 0 0 0 1
and benchmarking and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 7 0 0 0 0 1
(www.doi.org/10.7303/syn15667962) or (www.doi.org/10.7303/syn15667962) ( (w (ww (www BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 4 (.././)- 8 6 0 0 0 0 1
(https://drugtargetcommons.fimm.fi/). We (https://drugtargetcommons.fimm.fi/). ( (h (ht (htt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 1 6 4 (://../).- 10 9 0 0 0 0 1
continuously-updated resource continuously-updated c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 - 1 8 0 0 0 0 1
experimentally test experimentally e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 8 0 0 0 0 1
repurposing applications. repurposing r re rep repu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 . 1 2 0 0 0 0 1
Online Methods online O On Onl Onli BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 8 no 0 10 0 0 0 0 1
Challenge infrastructure challenge C Ch Cha Chal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 8 no 0 3 0 0 0 0 1
The Challenge the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 8 . 1 8 0 0 0 0 1
prediction files prediction p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 no 0 9 0 0 0 0 1
and individuals and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 ,. 2 9 0 0 0 0 1
infrastructure scripts infrastructure i in inf infr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 no 0 9 0 0 0 0 1
https://github.com/Sage-Bionetworks/IDG-DREAM-Drug-Kinase-Challenge . https://github.com/sage-bionetworks/idg-dream-drug-kinase-challenge h ht htt http BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 1 6 8 ://./-/----. 12 8 0 0 0 0 1
permitted to permitted p pe per perm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 ,(.. 4 9 0 0 0 0 1
3). For 3). 3 3) 3). 3). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 ).,- 4 8 0 0 0 0 1
to perform to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 :() 3 9 0 0 0 0 1
correct file correct c co cor corr BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 no 0 10 0 0 0 0 1
invalid, (2) invalid, i in inv inva BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,(), 4 10 0 0 0 0 1
and (3) and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ()., 4 8 0 0 0 0 1
submission a submission s su sub subm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 9 0 0 0 0 1
model overfitting. model m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .(): 4 8 0 0 0 0 1
infrastructure receive infrastructure i in inf infr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 9 0 0 0 0 1
team, and team, t te tea team BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,, 2 8 0 0 0 0 1
calculate a calculate c ca cal calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (); 3 9 0 0 0 0 1
return an return r re ret retu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (). 3 9 0 0 0 0 1
Bioactivity data bioactivity B Bi Bio Bioa BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 2 no 0 3 0 0 0 0 1
To generate to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 2 , 1 10 0 0 0 0 1
to DiscoverX to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 ()- 3 8 0 0 0 0 1
constant (K constant c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 (),. 4 9 0 0 0 0 1
relative compound relative r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 ,,-(), 6 10 0 0 0 0 1
where K where w wh whe wher BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 []., 4 10 0 0 0 0 1
compound against compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 .( 2 9 0 0 0 0 1
and 25 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 )- 2 9 0 0 0 0 1
already had already a al alr alre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 - 1 9 0 0 0 0 1
panel. This panel. p pa pan pane BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 .() 3 8 0 0 0 0 1
concentration of concentration c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 .-, 3 9 0 0 0 0 1
studies 3-5,5 studies s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 -,, 3 1 0 0 0 0 1
using using using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 no 0 0 0 0 0 0 1
the the the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 no 0 0 0 0 0 0 1
DiscoverX DiscoverX discoverx D Di Dis Disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 2 no 0 1 0 0 0 0 1
KINOME scan kinome K KI KIN KINO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 2 no 0 1 0 0 0 0 1
standard standard standard s st sta stan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 no 0 0 0 0 0 0 1
protocol protocol protocol p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 no 0 0 0 0 0 0 1
( https://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kino ( ( ( ( ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 2 (://..//---/-/ 14 9 0 0 0 0 1
mescan ). mescan m me mes mesc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 ).-- 4 9 0 0 0 0 1
that had that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 -. 2 8 0 0 0 0 1
stocks in stocks s st sto stoc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 2 ,. 2 6 0 0 0 0 1
25 of 25 2 25 25 25 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 7 - 1 9 0 0 0 0 1
studies, 5,11 studies, s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 ,,. 3 9 0 0 0 0 1
between these between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 -'.(.. 6 8 0 0 0 0 1
12A), providing 12a), 1 12 12A 12A) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 ),. 3 9 0 0 0 0 1
25 pK 25 2 25 25 25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 7 ', 2 9 0 0 0 0 1
larger set larger l la lar larg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 no 0 9 0 0 0 0 1
target profiling target t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 ,.. 3 10 0 0 0 0 1
correlation of correlation c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 .(..), 6 9 0 0 0 0 1
good reproducibility good g go goo good BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 7 . 1 8 0 0 0 0 1
when determining when w wh whe when BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 no 0 9 0 0 0 0 1
models in models m mo mod mode BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 (). 3 5 0 0 0 0 1
To subsequently to T To To To BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 -- 2 10 0 0 0 0 1
that were that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 , 1 9 0 0 0 0 1
potency based potency p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 -(...,- 7 9 0 0 0 0 1
and AIWIC), and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 ),-. 4 9 0 0 0 0 1
across the across a ac acr acro BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 -, 2 8 0 0 0 0 1
(Supplementary Fig. (supplementary ( (S (Su (Sup BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (.;:-). 7 10 0 0 0 0 1
One of one O On One One BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 (-), 4 9 0 0 0 0 1
for that for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 9 0 0 0 0 1
compound-kinase pairs compound-kinase c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 --. 3 9 0 0 0 0 1
compounds (GW819776) compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (), 3 8 0 0 0 0 1
were supplied were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 9 0 0 0 0 1
KINOMEscan competitive kinomescan K KI KIN KINO BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 8 0 0 0 0 1
Scoring of scoring S Sc Sco Scor BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 2 no 0 3 0 0 0 0 1
We used we W We We We BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 2 : 1 8 0 0 0 0 1
 Root-mean-square      BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 2 --(): 6 8 0 0 0 0 1
between the between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 ,. 2 9 0 0 0 0 1
 Pearson      BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 2 : 2 8 0 0 0 0 1
measured pK measured m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 ',. 3 9 0 0 0 0 1
 Spearman      BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 2 :' 3 9 0 0 0 0 1
and measured and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 ',. 3 8 0 0 0 0 1
 Concordance      BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 2 (): 4 9 0 0 0 0 1
compound-kinase pairs compound-kinase c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 -. 2 8 0 0 0 0 1
 F1      BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 2 :. 3 9 0 0 0 0 1
binarized by binarized b bi bin bina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 ()(). 5 10 0 0 0 0 1
 Average      BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 2 :() 4 9 0 0 0 0 1
generated using generated g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 [,] 3 9 0 0 0 0 1
pK d pk p pK pK pK BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 2 '. 2 3 0 0 0 0 1
The submissions the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 8 0 0 0 0 1
unranked. The unranked. u un unr unra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 .-,- 4 9 0 0 0 0 1
determined based determined d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ,. 2 9 0 0 0 0 1
evaluated the evaluated e ev eva eval BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 - 1 10 0 0 0 0 1
the measured the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 , 1 9 0 0 0 0 1
binding affinity binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 .- 2 10 0 0 0 0 1
curve (AUC) curve c cu cur curv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 () 2 9 0 0 0 0 1
active and active a ac act acti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 . 1 6 0 0 0 0 1
Statistical evaluation statistical S St Sta Stat BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 9 no 0 4 0 0 0 0 1
Determination of determination D De Det Dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 9 - 1 9 0 0 0 0 1
top-ranked submission top-ranked t to top top- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 -.,( 4 9 0 0 0 0 1
iterations of iterations i it ite iter BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 ), 2 9 0 0 0 0 1
test dataset test t te tes test BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 . 1 9 0 0 0 0 1
calculated using calculated c ca cal calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 no 0 4 0 0 0 0 1
( https://github.com/sage-bionetworks/challengescoring ( ( ( ( ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 9 (://./-/) 9 10 0 0 0 0 1
submission in submission s su sub subm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 . 1 9 0 0 0 0 1
submission were submission s su sub subm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 -. 2 9 0 0 0 0 1
was performed was w wa was was BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 . 1 8 0 0 0 0 1
To create to T To To To BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 ,/ 2 10 0 0 0 0 1
across the across a ac acr acro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 /-/, 4 9 0 0 0 0 1
repeated the repeated r re rep repe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 . 1 9 0 0 0 0 1
1/Round 2 1/round 1 1/ 1/R 1/Ro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 /. 2 9 0 0 0 0 1
defined a defined d de def defi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 10 0 0 0 0 1
10000 random 10000 1 10 100 1000 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 8 0 (.,). 5 6 0 0 0 0 1
To determine to T To To To BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 1 no 0 9 0 0 0 0 1
models, we models, m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 , 1 3 0 0 0 0 1
measurements from measurements m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 no 0 6 0 0 0 0 1
biochemical assay biochemical b bi bio bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 . 1 8 0 0 0 0 1
replicated K replicated r re rep repl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 , 1 9 0 0 0 0 1
respectively. These respectively. r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .,. 3 9 0 0 0 0 1
represent the represent r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 , 1 10 0 0 0 0 1
(Round 1) (round ( (R (Ro (Rou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ()(), 5 9 0 0 0 0 1
values in values v va val valu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .,, 3 8 0 0 0 0 1
randomly selected randomly r ra ran rand BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .,, 3 9 0 0 0 0 1
randomly selected randomly r ra ran rand BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 . 1 9 0 0 0 0 1
these compound-kinase these t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 -(), 4 8 0 0 0 0 1
RMSE between rmse R RM RMS RMSE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 1 '- 2 8 0 0 0 0 1
1 and 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 8 1 ,,. 3 8 0 0 0 0 1
Baseline model baseline B Ba Bas Base BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 no 0 1 0 0 0 0 1
We used we W We We We BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 -- 2 9 0 0 0 0 1
baseline model baseline b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 -. 2 9 0 0 0 0 1
of 44186 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 (). 3 8 0 0 0 0 1
Median was median M Me Med Medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 - 1 9 0 0 0 0 1
pair. We pair. p pa pai pair BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .- 2 9 0 0 0 0 1
between full between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 , 1 8 0 0 0 0 1
following fingerprints following f fo fol foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 :()- 4 9 0 0 0 0 1
PubChem ( pubchem P Pu Pub PubC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 (),()--(),()- 13 9 0 0 0 0 1
based on based b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 8 0 0 0 0 1
( shortestpath ( ( ( ( ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 6 (),()- 6 9 0 0 0 0 1
to 6 to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 (;).( 5 9 0 0 0 0 1
at https://github.com/aatapa/RLScore at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ://.//).- 9 9 0 0 0 0 1
evaluate the evaluate e ev eva eval BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 9 0 0 0 0 1
kernels as kernels k ke ker kern BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ., 2 10 0 0 0 0 1
majority of majority m ma maj majo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 9 0 0 0 0 1
the public the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ,--- 4 9 0 0 0 0 1
the setting the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 9 0 0 0 0 1
coupled with coupled c co cou coup BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 -() 3 9 0 0 0 0 1
predictive performance predictive p pr pre pred BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 (), 3 9 0 0 0 0 1
used as used u us use used BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 - 1 10 0 0 0 0 1
Rounds. Rounds. rounds. R Ro Rou Roun BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 . 1 0 0 0 0 0 1
Top-performing models top-performing T To Top Top- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 - 1 2 0 0 0 0 1
Supplementary write supplementary S Su Sup Supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 9 0 0 0 0 1
( http://www.doi.org/10.7303/syn21445941.1 ( ( ( ( ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 0 (://.././.).- 13 10 0 0 0 0 1
are listed are a ar are are BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 . 1 4 0 0 0 0 1
Team Q.E.D team T Te Tea Team BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 1 .. 2 1 0 0 0 0 1
To enable to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 1 -(.., 5 9 0 0 0 0 1
family members), family f fa fam fami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ),.. 4 8 0 0 0 0 1
targets as targets t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 . 1 9 0 0 0 0 1
an ensemble an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 1 (),, 4 9 0 0 0 0 1
different choices different d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 [.,.,.,.,.],[,, 15 9 0 0 0 0 1
, 500], ,  , , , BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 1 ,],: 4 8 0 0 0 0 1
normalized striped normalized n no nor norm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 - 1 8 0 0 0 0 1
( https://github.com/mengyao/Complete-Striped-Smith-Waterman-Library ( ( ( ( ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 1 (://.//----). 13 8 0 0 0 0 1
alternatives of alternatives a al alt alte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 no 0 8 0 0 0 0 1
similarity metrics similarity s si sim simi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 -(''[,] 7 9 0 0 0 0 1
'useChirality' [True, 'usechirality' ' 'u 'us 'use BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ''[,],://.//). 14 10 0 0 0 0 1
baseline method, baseline b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ,, 2 8 0 0 0 0 1
Q.E.D model q.e.d Q Q. Q.E Q.E. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 1 ..,. 4 9 0 0 0 0 1
the same the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 -, 2 8 0 0 0 0 1
affinity values affinity a af aff affi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 . 1 8 0 0 0 0 1
Team DMIS_DK team T Te Tea Team BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 1 0 0 0 0 1
Team DMIS_DK team T Te Tea Team BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 -() 3 8 0 0 0 0 1
bioactivity values bioactivity b bi bio bioa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 no 0 8 0 0 0 0 1
BindingDB. Three bindingdb. B Bi Bin Bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 .,,,,. 6 10 0 0 0 0 1
computed if computed c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 -.- 3 9 0 0 0 0 1
GCN model gcn G GC GCN GCN BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 , 1 8 0 0 0 0 1
converted to converted c co con conv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 (://..).(.. 11 9 0 0 0 0 1
atom) in atom) a at ato atom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 )-, 3 8 0 0 0 0 1
information of information i in inf info BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ,,, 3 8 0 0 0 0 1
graph, and graph, g gr gra grap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ,.. 3 8 0 0 0 0 1
ensemble of ensemble e en ens ense BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 - 1 8 0 0 0 0 1
( http://www.doi.org/10.7303/syn21445941.1 ( ( ( ( ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 6 (://.././.)., 13 9 0 0 0 0 1
predictions from predictions p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 , 1 8 0 0 0 0 1
multi-task GCN multi-task m mu mul mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 -(). 4 9 0 0 0 0 1
Hyper-parameters of hyper-parameters H Hy Hyp Hype BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 -- 2 8 0 0 0 0 1
hold-out set hold-out h ho hol hold BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 -. 2 8 0 0 0 0 1
PyTorch Geometric pytorch P Py PyT PyTo BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 (). 3 3 0 0 0 0 1
Team AI team T Te Tea Team BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 3 0 0 0 0 1
Team AI team T Te Tea Team BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 0 0 0 0 1
(GBDT) implemented (gbdt) ( (G (GB (GBD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ().,,, 6 10 0 0 0 0 1
and pEC and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (), 3 7 0 0 0 0 1
compound-protein pairs compound-protein c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -'' 3 8 0 0 0 0 1
'functional' human 'functional' ' 'f 'fu 'fun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ''., 4 9 0 0 0 0 1
different bioactivities different d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 () 2 9 0 0 0 0 1
excluded. For excluded. e ex exc excl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ., 2 9 0 0 0 0 1
for inclusion for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .- 2 9 0 0 0 0 1
feature vector feature f fe fea feat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ,,, 3 9 0 0 0 0 1
and 11. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .. 2 9 0 0 0 0 1
protein target protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -(), 4 9 0 0 0 0 1
perform hyperparameter perform p pe per perf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 0 0 0 0 1
prediction was prediction p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 9 0 0 0 0 1
based on based b ba bas base BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 2 0 0 0 0 1
Mean ensemble mean M Me Mea Mean BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 no 0 3 0 0 0 0 1
Ensemble models ensemble E En Ens Ense BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 - 1 9 0 0 0 0 1
team. We team. t te tea team BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .(.. 4 10 0 0 0 0 1
ensemble #1 ensemble e en ens ense BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 #-,#-,#- 8 9 0 0 0 0 1
highest scoring, highest h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ,). 3 9 0 0 0 0 1
created using created c cr cre crea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ,,-. 4 9 0 0 0 0 1
rank-weighted ensemble rank-weighted r ra ran rank BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 - 1 9 0 0 0 0 1
number of number n nu num numb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 , 1 9 0 0 0 0 1
predictions, and predictions, p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ,. 2 9 0 0 0 0 1
predictions for predictions p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 no 0 9 0 0 0 0 1
calculated as calculated c ca cal calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 no 0 9 0 0 0 0 1
the top the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 . 1 2 0 0 0 0 1
Estimating the estimating E Es Est Esti BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 8 no 0 4 0 0 0 0 1
The KINOMEscan the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 8 -- 2 9 0 0 0 0 1
based on based b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 , 1 9 0 0 0 0 1
1000 nM 1000 1 10 100 1000 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 9 8 .-, 3 10 0 0 0 0 1
the dose-response the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 -- 2 9 0 0 0 0 1
(at 1000 (at ( (a (at (at BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 8 (): 3 7 0 0 0 0 1
ligand occupancy/expected ligand l li lig liga BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 10 / 1 10 0 0 0 0 1
% % % % % % % BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 10 no 0 0 0 0 0 0 1
= = = = = = = BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 10 no 0 0 0 0 0 0 1
M aximum m M M M M BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 10 no 0 5 0 0 0 0 1
M aximum m M M M M BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 10 ()() 4 10 0 0 0 0 1
where where where w wh whe wher BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 11 no 0 2 0 0 0 0 1
aximum ligand aximum a ax axi axim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 11 no 0 10 0 0 0 0 1
1e 1e 1e 1 1e 1e 1e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 11 no 0 1 0 0 0 0 1
6 M 6 6 6 6 6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 9 11 no 0 1 0 0 0 0 1
M M m M M M M BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 11 no 0 0 0 0 0 0 1
= = = = = = = BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 11 no 0 0 0 0 0 0 1
 0      BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 11  1 1 0 0 0 0 1
The expected the T Th The The BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 11 : 1 10 0 0 0 0 1
Measured pK measured M Me Mea Meas BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 10 0 0 0 0 1
Measured K measured M Me Mea Meas BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 [] 2 7 0 0 0 0 1
Expected inhibition expected E Ex Exp Expe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 [] 2 10 0 0 0 0 1
3 3 3 3 3 3 3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 9 0 no 0 2 0 0 0 0 1
1e -03 1e 1 1e 1e 1e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 - 1 10 0 0 0 0 1
0 0 0 0 0 0 0 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 9 0 no 0 2 0 0 0 0 1
4 4 4 4 4 4 4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 9 0 no 0 2 0 0 0 0 1
1e -04 1e 1 1e 1e 1e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 - 1 10 0 0 0 0 1
1 1 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 9 0 no 0 2 0 0 0 0 1
5 5 5 5 5 5 5 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 9 0 no 0 2 0 0 0 0 1
1e -05 1e 1 1e 1e 1e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 - 1 10 0 0 0 0 1
10 10 10 1 10 10 10 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 no 0 4 0 0 0 0 1
6 6 6 6 6 6 6 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 10 0 no 0 2 0 0 0 0 1
1e -06 1e 1 1e 1e 1e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 - 1 10 0 0 0 0 1
50 50 50 5 50 50 50 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 0 no 0 4 0 0 0 0 1
7 7 7 7 7 7 7 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 10 1 no 0 2 0 0 0 0 1
1e -07 1e 1 1e 1e 1e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 - 1 10 0 0 0 0 1
91 91 91 9 91 91 91 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 1 no 0 4 0 0 0 0 1
8 8 8 8 8 8 8 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 10 1 no 0 2 0 0 0 0 1
1e -08 1e 1 1e 1e 1e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 - 1 10 0 0 0 0 1
99 99 99 9 99 99 99 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 1 no 0 4 0 0 0 0 1
9 9 9 9 9 9 9 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 10 1 no 0 2 0 0 0 0 1
1e -09 1e 1 1e 1e 1e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 - 1 10 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 1 no 0 5 0 0 0 0 1
Activity classification activity A Ac Act Acti BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 1 no 0 3 0 0 0 0 1
Standard confusion standard S St Sta Stan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 1 no 0 9 0 0 0 0 1
positive and positive p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 , 1 9 0 0 0 0 1
for indicating for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 , 1 9 0 0 0 0 1
pairs were pairs p pa pai pair BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 -,- 3 9 0 0 0 0 1
of 80%, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 ,,,..-, 7 10 0 0 0 0 1
the measured the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 (..,).() 8 9 0 0 0 0 1
false discovery false f fa fal fals BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 (). 3 8 0 0 0 0 1
To carry to T To To To BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 , 1 9 0 0 0 0 1
ranked both ranked r ra ran rank BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ..-- 4 9 0 0 0 0 1
values, and values, v va val valu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,- 2 9 0 0 0 0 1
based on based b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -( 2 9 0 0 0 0 1
positive activity). positive p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ).() 4 10 0 0 0 0 1
and precision-recall and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -(),-, 6 7 0 0 0 0 1
respectively 30,31 respectively r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,. 2 8 0 0 0 0 1
classification performance. classification c cl cla clas BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 . 1 2 0 0 0 0 1
Data and data D Da Dat Data BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 8 no 0 2 0 0 0 0 1
The Challenge the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 8 (://../). 9 9 0 0 0 0 1
The Docker the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 8 - 1 9 0 0 0 0 1
this Challenge this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 (.././). 8 10 0 0 0 0 1
figures figures figures f fi fig figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 no 0 0 0 0 0 0 1
are are are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 no 0 0 0 0 0 0 1
available available available a av ava avai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 no 0 1 0 0 0 0 1
at at at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 no 0 0 0 0 0 0 1
GitHub GitHub github G Gi Git GitH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 8 no 0 0 0 0 0 0 1
( https://github.com/Sage-Bionetworks/IDG-DREAM-Challenge-Analysis/ ( ( ( ( ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 8 (://./-/---/). 14 9 0 0 0 0 1
for this for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 no 0 9 0 0 0 0 1
synapser 33 synapser s sy syn syna BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 8 ; 1 9 0 0 0 0 1
previously mentioned previously p pr pre prev BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 . 1 4 0 0 0 0 1
Acknowledgements Acknowledgements acknowledgements A Ac Ack Ackn BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 1 0 0 0 0 1
The authors the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 9 0 0 0 0 1
unpublished target unpublished u un unp unpu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 , 1 9 0 0 0 0 1
Hansson (University hansson H Ha Han Hans BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 0 (,), 4 10 0 0 0 0 1
Tianduanyi Wang tianduanyi T Ti Tia Tian BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 (), 3 9 0 0 0 0 1
(University of (university ( (U (Un (Uni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 (,)-(,) 7 9 0 0 0 0 1
organizing the organizing o or org orga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 , 1 9 0 0 0 0 1
bioactivity profiling bioactivity b bi bio bioa BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 (). 3 6 0 0 0 0 1
Funding: Funding: funding: F Fu Fun Fund BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 2 : 1 10 0 0 0 0 1
TA: Academy ta: T TA TA: TA: BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 :(,),, 6 10 0 0 0 0 1
Juslius Foundation. juslius J Ju Jus Jus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 .,,:(-). 8 10 0 0 0 0 1
is a is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 ,, 2 9 0 0 0 0 1
Ingelheim, Canada ingelheim, I In Ing Inge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 ,,, 3 9 0 0 0 0 1
Canada, Innovative canada, C Ca Can Cana BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 ,(-),,, 7 10 0 0 0 0 1
Kga, Merck kga, K Kg Kga Kga, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 ,,, 3 9 0 0 0 0 1
and Innovation, and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 ,,-,. 5 8 0 0 0 0 1
IDG-DREAM Drug idg-dream I ID IDG IDG- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 -: 2 10 0 0 0 0 1
User oselot: user U Us Use User BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 5 :;:-,..,-, 10 9 0 0 0 0 1
Chih-Hsun Wu, chih-hsun C Ch Chi Chih BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 -,-,-,-;: 9 9 0 0 0 0 1
Xiaokang Wang, xiaokang X Xi Xia Xiao BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,;: 5 9 0 0 0 0 1
Nguyen; Team nguyen; N Ng Ngu Nguy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ;:,,,,: 7 8 0 0 0 0 1
Hakime ztrk, hakime H Ha Hak Haki BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,;:, 5 9 0 0 0 0 1
Bilgin; Team bilgin; B Bi Bil Bilg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ;:,;--: 7 9 0 0 0 0 1
K. Kanev, k. K K. K. K. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .,.,.;: 7 9 0 0 0 0 1
Terzopoulos, Konstantinos terzopoulos, T Te Ter Terz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,; 4 9 0 0 0 0 1
KERMIT-LAB -Ghent kermit-lab K KE KER KERM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 --:,,, 6 9 0 0 0 0 1
Briers; Team briers; B Br Bri Brie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ;:,,,,,; 8 10 0 0 0 0 1
Team METU_EMBLEBI_CROssBAR: team T Te Tea Team BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 :,.,, 5 8 0 0 0 0 1
Cetin Atalay, cetin C Ce Cet Ceti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,.;:,, 7 9 0 0 0 0 1
Sunkyu Kim, sunkyu S Su Sun Sunk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,,,; 6 9 0 0 0 0 1
Winter is winter W Wi Win Wint BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 5 :,,;: 5 9 0 0 0 0 1
Szalai, Gabor szalai, S Sz Sza Szal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,;-:, 7 9 0 0 0 0 1
Prasse, Ivo prasse, P Pr Pra Pras BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,,,: 6 9 0 0 0 0 1
Oroli, Bono oroli, O Or Or Oro BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,, 3 5 0 0 0 0 1
References References references R Re Ref Refe BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 10 0 0 0 0 1
1. Arrowsmith, 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,......., 10 10 0 0 0 0 1
536-541 (2015). 536-541 5 53 536 536- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -(). 4 10 0 0 0 0 1
2. Santos, 2. 2 2. 2. 2. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 .,...... 8 10 0 0 0 0 1
16 , 16 1 16 16 16 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 1 , 1 0 0 0 0 0 1
19-34 (2017). 19-34 1 19 19- 19-3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 -(). 4 10 0 0 0 0 1
3. Fabian, 3. 3 3. 3. 3. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 2 .,...-.. 8 10 0 0 0 0 1
Biotechnol. 23 biotechnol. B Bi Bio Biot BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 .,-(). 6 10 0 0 0 0 1
4. Davis, 4. 4 4. 4. 4. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 3 .,...... 8 10 0 0 0 0 1
29 , 29 2 29 29 29 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 3 , 1 0 0 0 0 0 1
1046-1051 (2011). 1046-1051 1 10 104 1046 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 4 -(). 4 10 0 0 0 0 1
5. Elkins, 5. 5 5. 5. 5. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 .,..... 7 10 0 0 0 0 1
Biotechnol. 34 biotechnol. B Bi Bio Biot BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 .,-(). 6 10 0 0 0 0 1
6. Mendez, 6. 6 6. 6. 6. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .,..:.. 7 10 0 0 0 0 1
47 , 47 4 47 47 47 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 5 ,-(). 5 10 0 0 0 0 1
7. Gilson, 7. 7 7. 7. 7. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,...:, 7 10 0 0 0 0 1
computational chemistry computational c co com comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ..,- 4 10 0 0 0 0 1
(2016). (2016). (2016). ( (2 (20 (201 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 7 (). 3 10 0 0 0 0 1
8. Oprea, 8. 8 8. 8. 8. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 7 .,...... 8 10 0 0 0 0 1
Discov. 17 discov. D Di Dis Disc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 8 .,-(). 6 10 0 0 0 0 1
9. Tang, 9. 9 9. 9. 9. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .,..: 5 10 0 0 0 0 1
Base for base B Ba Bas Base BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 9 -...,-.(). 10 10 0 0 0 0 1
10. 10. 10. 1 10 10. 10. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 10 . 1 0 0 0 0 0 1
Omberg, L. omberg, O Om Omb Ombe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 10 ,.. 3 10 0 0 0 0 1
tumor types tumor t tu tum tumo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 ... 3 10 0 0 0 0 1
45 , 45 4 45 45 45 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 10 ,-(). 5 4 0 0 0 0 1
11. 11. 11. 1 11 11. 11. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 11 . 1 0 0 0 0 0 1
Drewry, D. drewry, D Dr Dre Drew BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 ,... 4 10 0 0 0 0 1
a call a a a a a BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 11 0 .,(). 5 10 0 0 0 0 1
12. 12. 12. 1 12 12. 12. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 . 1 0 0 0 0 0 1
Cichonska, A. cichonska, C Ci Cic Cich BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,..-- 5 10 0 0 0 0 1
mapping: A mapping: m ma map mapp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 :...,(). 8 10 0 0 0 0 1
13. 13. 13. 1 13 13. 13. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 1 . 1 0 0 0 0 0 1
Wells, C. wells, W We Wel Well BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 1 ,..,,..,,..,.. 14 10 0 0 0 0 1
cross screening cross c cr cro cros BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 2 no 0 10 0 0 0 0 1
kinases. MedChemComm kinases. k ki kin kina BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 2 .,-(). 6 10 0 0 0 0 1
14. 14. 14. 1 14 14. 14. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 3 . 1 0 0 0 0 0 1
Ertl, P. ertl, E Er Ert Ertl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 ,.: 3 10 0 0 0 0 1
Common Substituents, common C Co Com Comm BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 3 ,, 2 10 0 0 0 0 1
Drug-like Bioisosteric drug-like D Dr Dru Drug BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 4 -......,-(). 12 10 0 0 0 0 1
15. 15. 15. 1 15 15. 15. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 . 1 0 0 0 0 0 1
Reymond, J.-L. reymond, R Re Rey Reym BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 ,.-.,. 6 10 0 0 0 0 1
Chemical Universe chemical C Ch Che Chem BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 5 ... 3 10 0 0 0 0 1
3 , 3 3 3 3 3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 11 5 ,-(). 5 4 0 0 0 0 1
16. 16. 16. 1 16 16. 16. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 . 1 0 0 0 0 0 1
Vamathevan, J. vamathevan, V Va Vam Vama BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,.. 3 10 0 0 0 0 1
development. Nat. development. d de dev deve BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .... 4 10 0 0 0 0 1
18 , 18 1 18 18 18 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 6 ,-(). 5 5 0 0 0 0 1
17. 17. 17. 1 17 17. 17. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 . 1 0 0 0 0 0 1
Marbach, D. marbach, M Ma Mar Marb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.... 5 10 0 0 0 0 1
9 , 9 9 9 9 9 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 11 6 , 1 0 0 0 0 0 1
796-804 (2012). 796-804 7 79 796 796- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 7 -(). 4 10 0 0 0 0 1
18. 18. 18. 1 18 18. 18. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 7 . 1 0 0 0 0 0 1
Eduati, F. eduati, E Ed Edu Edua BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 7 ,.. 3 10 0 0 0 0 1
collaborative competition. collaborative c co col coll BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 8 ...,-(). 8 10 0 0 0 0 1
19. 19. 19. 1 19 19. 19. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 . 1 0 0 0 0 0 1
Saez-Rodriguez, J. saez-rodriguez, S Sa Sae Saez BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 8 -,..: 5 10 0 0 0 0 1
as innovation as a as as as BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 9 .... 4 10 0 0 0 0 1
17 , 17 1 17 17 17 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 9 ,-(). 5 5 0 0 0 0 1
20. 20. 20. 2 20 20. 20. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 9 . 1 0 0 0 0 0 1
Guinney, J. guinney, G Gu Gui Guin BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 9 ,.-,. 5 10 0 0 0 0 1
data. Nat. data. d da dat data BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 ...,-(). 8 10 0 0 0 0 1
21. 21. 21. 2 21 21. 21. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 10 . 1 0 0 0 0 0 1
Neto, E. neto, N Ne Net Neto BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 10 ,...-.. 7 10 0 0 0 0 1
ArXiv160700091 (2016). arxiv160700091 A Ar ArX ArXi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 11 (). 3 10 0 0 0 0 1
22. 22. 22. 2 22 22. 22. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 11 . 1 0 0 0 0 0 1
Pahikkala, T. pahikkala, P Pa Pah Pahi BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 ,..-.. 6 10 0 0 0 0 1
Bioinform. 16 bioinform. B Bi Bio Bioi BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .,-(). 6 10 0 0 0 0 1
23. 23. 23. 2 23 23. 23. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 . 1 0 0 0 0 0 1
Guha, R. guha, G Gu Guh Guha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,..... 6 10 0 0 0 0 1
18 , 18 1 18 18 18 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 0 ,-(). 5 2 0 0 0 0 1
24. 24. 24. 2 24 24. 24. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 1 . 1 0 0 0 0 0 1
Airola, A. airola, A Ai Air Airo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 1 ,.,. 4 10 0 0 0 0 1
Trick. IEEE trick. T Tr Tri Tric BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 1 ..... 5 10 0 0 0 0 1
29 , 29 2 29 29 29 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 1 ,-(). 5 5 0 0 0 0 1
25. 25. 25. 2 25 25. 25. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 2 . 1 0 0 0 0 0 1
Pahikkala, T. pahikkala, P Pa Pah Pahi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 2 ,.,.:-... 9 10 0 0 0 0 1
Learn. Res. learn. L Le Lea Lear BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 2 ..,-(). 7 10 0 0 0 0 1
26. 26. 26. 2 26 26. 26. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 3 . 1 0 0 0 0 0 1
Zhao, M., zhao, Z Zh Zha Zhao BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 ,.,,.-.,,..,..: 15 10 0 0 0 0 1
Smith-Waterman C/C++ smith-waterman S Sm Smi Smit BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 -/.,(). 7 10 0 0 0 0 1
27. 27. 27. 2 27 27. 27. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 . 1 0 0 0 0 0 1
Rogers, D. rogers, R Ro Rog Roge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 ,.,.-..... 10 10 0 0 0 0 1
50 , 50 5 50 50 50 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 4 , 1 0 0 0 0 0 1
742-754 (2010). 742-754 7 74 742 742- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 -(). 4 10 0 0 0 0 1
28. 28. 28. 2 28 28. 28. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 . 1 0 0 0 0 0 1
Fey, M. fey, F Fe Fey Fey, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,.,... 6 10 0 0 0 0 1
ArXiv190302428 Cs arxiv190302428 A Ar ArX ArXi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 (). 3 10 0 0 0 0 1
29. 29. 29. 2 29 29. 29. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 . 1 0 0 0 0 0 1
Chen, T. chen, C Ch Che Chen BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.,.:. 6 10 0 0 0 0 1
the 22Nd the t th the the BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 7 no 0 10 0 0 0 0 1
785-794 (ACM, 785-794 7 78 785 785- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 7 -(,).:./.. 10 10 0 0 0 0 1
30. 30. 30. 3 30 30. 30. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 . 1 0 0 0 0 0 1
Robin, X. robin, R Ro Rob Robi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 8 ,..:- 5 10 0 0 0 0 1
ROC curves. roc R RO ROC ROC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 8 . 1 10 0 0 0 0 1
12 , 12 1 12 12 12 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 8 ,(). 4 5 0 0 0 0 1
31. 31. 31. 3 31 31. 31. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 9 . 1 0 0 0 0 0 1
Grau, J., grau, G Gr Gra Grau BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 9 ,.,,.,.:- 9 10 0 0 0 0 1
and receiver and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 9 .... 4 10 0 0 0 0 1
31 , 31 3 31 31 31 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 9 ,- 2 2 0 0 0 0 1
(2015). (2015). (2015). ( (2 (20 (201 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 10 (). 3 10 0 0 0 0 1
32. 32. 32. 3 32 32. 32. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 10 . 1 0 0 0 0 0 1
Wickham, H. wickham, W Wi Wic Wick BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 10 ,..... 6 10 0 0 0 0 1
4 , 4 4 4 4 4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 11 10 ,(). 4 2 0 0 0 0 1
33. 33. 33. 3 33 33. 33. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 11 . 1 0 0 0 0 0 1
Hoff, B. hoff, H Ho Hof Hoff BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 ,.,.:.(). 9 10 0 0 0 0 1

